[go: up one dir, main page]

AU505133B2 - Azetidinone derivatives - Google Patents

Azetidinone derivatives

Info

Publication number
AU505133B2
AU505133B2 AU82778/75A AU8277875A AU505133B2 AU 505133 B2 AU505133 B2 AU 505133B2 AU 82778/75 A AU82778/75 A AU 82778/75A AU 8277875 A AU8277875 A AU 8277875A AU 505133 B2 AU505133 B2 AU 505133B2
Authority
AU
Australia
Prior art keywords
azetidinone derivatives
azetidinone
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU82778/75A
Other versions
AU8277875A (en
Inventor
T. SAITO Y. HASHIMOTO M. SERAJI T. TAKAYA T. KOMORI T. OSAMU N. OKU T. SHIOKAWA Y. DEMMY K. Sc TAKASUGI H KAMIYA
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP265074A external-priority patent/JPS572598B2/ja
Priority claimed from JP49077091A external-priority patent/JPS51125061A/en
Priority claimed from JP49085526A external-priority patent/JPS51125062A/en
Priority claimed from JP49088452A external-priority patent/JPS51125064A/en
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of AU8277875A publication Critical patent/AU8277875A/en
Application granted granted Critical
Publication of AU505133B2 publication Critical patent/AU505133B2/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU82778/75A 1973-12-28 1975-07-04 Azetidinone derivatives Expired AU505133B2 (en)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
JP265074A JPS572598B2 (en) 1973-12-28 1973-12-28
JP49077091A JPS51125061A (en) 1974-07-04 1974-07-04 A process for 3-acylaminoazetidinone derivatives
JPJP77091/74 1974-07-04
JP49085526A JPS51125062A (en) 1974-07-24 1974-07-24 A process for preparing 3-aminoazetidinone
JPJP85526/74 1974-07-24
JPJP88452/74 1974-07-31
JP49088452A JPS51125064A (en) 1974-07-31 1974-07-31 A process for preparing 1-substituted-3- acylaminoazetidinone derivati ves
JPJP2650/75 1974-12-23

Publications (2)

Publication Number Publication Date
AU8277875A AU8277875A (en) 1977-01-06
AU505133B2 true AU505133B2 (en) 1979-11-08

Family

ID=27453684

Family Applications (1)

Application Number Title Priority Date Filing Date
AU82778/75A Expired AU505133B2 (en) 1973-12-28 1975-07-04 Azetidinone derivatives

Country Status (2)

Country Link
AU (1) AU505133B2 (en)
IE (1) IE42215B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU749658B2 (en) * 1996-12-23 2002-06-27 Elan Pharmaceuticals, Inc. Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU749658B2 (en) * 1996-12-23 2002-06-27 Elan Pharmaceuticals, Inc. Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
AU749658C (en) * 1996-12-23 2004-04-29 Elan Pharmaceuticals, Inc. Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds

Also Published As

Publication number Publication date
IE42215L (en) 1976-01-04
IE42215B1 (en) 1980-07-02
AU8277875A (en) 1977-01-06

Similar Documents

Publication Publication Date Title
AU468242B2 (en) 2-cyclohexene-1-one derivatives
CA1020171A (en) 2-methylbenzamide derivatives
CA1025856A (en) Quinoline-3-carboxamidotetrazole derivatives
CA1029036A (en) Octahydro-acetonaphthone derivatives
CA1018170A (en) Lactamimide derivatives
CA1019749A (en) Beneoxazolinone derivatives
AU474588B2 (en) Substituted pyrrolidinemethanols
AU474590B2 (en) Pyrazinoisoquinoline derivative
CA1034943A (en) Substituted phenylglycylcephalosporins
CA1026331A (en) Substituted indolobenzazepines
CA1022943A (en) Substituted ureido-s-triazines
AU505133B2 (en) Azetidinone derivatives
CA1024154A (en) Nor-sesquiterpene derivatives
AU458655B2 (en) Benzenesulfonylurea derivatives
AU5713873A (en) Benzalhydrazone derivative
CA1007249A (en) 4-alkoxy-4-phenylcyclohexylamine derivatives
CA1002947A (en) Imidazo-benzodiazepine derivatives
AU495842B2 (en) Ryrimidine derivatives
AU487016B2 (en) Debenzocycoheptene derivatives
AU480266B2 (en) 4-o-sulfonyl erythromycin-9-o-oxime derivatives
AU479245B2 (en) 8-azapurin-6-one derivatives
AU483899B2 (en) 7- methoxycephalosporin derivatives
AU479187B2 (en) Triazolobenzoidiazepine derivatives
AU470521B2 (en) 5-benzyl-pyrimidine derivatives
AU482770B2 (en) 4-deoxy-4-oxoerythromycin b derivatives